Jasmin Kümmerle-Deschner, MD

med.uni-tuebingen
Tübingen, Germany

.

Disclosure information not submitted.

Presentation(s):

• 0812: 3-years Safety and Efficacy Outcomes of Canakinumab Treatment in Cryopyrin-associated Periodic Syndromes (CAPS) – Data from the RELIANCE Registry

  Sunday, November 13, 2022
  9:00 AM – 10:30 AM Eastern Time

• 1842: Vaccination in Patients with Autoinflammatory Periodic Syndromes Under Canakinumab - Safety Data Interim Analysis of the RELIANCE Registry

  Monday, November 14, 2022
  1:00 PM – 3:00 PM Eastern Time